Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y 12 inhibitor has been the standard of care to prevent thrombotic events in patients with acute coronary syndrome (ACS) undergoing ...
Patients with acute coronary syndromes (ACS) with later bleeding complications that were at least moderate in severity showed a 15-fold increased risk of dying within 30 days compared with those ...
Giving statins before percutaneous coronary intervention (PCI) lowers the risk of 30-day events compared with post-PCI initiation or no or low-dose statins in patients with acute coronary syndromes ...
Patients with left main coronary artery disease who present with ACS fare just as well when treated with PCI as they do with CABG surgery, according to results of a new study. While ACS patients had ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Despite fewer bleeding events, 1-month ...
PARSIPPANY, N.J. and INDIANAPOLIS, March 29, 2011 /PRNewswire/ -- Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Long-term ticagrelor monotherapy after ...
ACS, which includes heart attack and unstable angina (chest pain), affects more than 1.5 million people in the United States annually, many of whom are managed with PCI. (1) In 2009, an estimated ...
"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...
For the first time, ESC Guidelines published today give the highest degree of recommendation for the radial approach over the femoral one for coronary angiography and percutaneous coronary ...
heart ecg A systematic review and meta-analysis published in the American Journal of Cardiovascular Drugs compared the safety and efficacy of prasugrel and ticagrelor in patients with acute coronary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback